Cancer Genetics and Epigenetics, 2025, Vol.13, No.5, 206-214 http://medscipublisher.com/index.php/cge 214 Marofi F., Achmad H., Bokov D., Kamal W., Alsadoon Z., Chupradit S., Suksatan W., Shariatzadeh S., Hasanpoor Z., Yazdanifar M., Shomali N., and Khiavi F., 2022, Hurdles to breakthrough in CAR T cell therapy of solid tumors, Stem Cell Research and Therapy, 13(1): 140. Marofi F., Motavalli R., Safonov V., Thangavelu L., Yumashev A., Alexander M., Shomali N., Chartrand M., Pathak Y., Jarahian M., Izadi S., Hassanzadeh A., Shirafkan N., Tahmasebi S., and Khiavi F., 2021, CAR T cells in solid tumors: challenges and opportunities, Stem Cell Research and Therapy, 12(1): 81. https://doi.org/10.1186/s13287-020-02128-1 Martinez M., and Moon E., 2019, CAR T cells for solid tumors: new strategies for finding infiltrating and surviving in the tumor microenvironment, Frontiers in Immunology, 10: 128. https://doi.org/10.3389/fimmu.2019.00128 Misawa K., Bhat H., Adusumilli P., and Hou Z., 2024, Combinational CAR T-cell therapy for solid tumors: requisites rationales and trials, Pharmacology and Therapeutics, 266: 108763. https://doi.org/10.1016/j.pharmthera.2024.108763 Rodríguez-García A., Palazón A., Noguera-Ortega E., Powell D., and Guedan S., 2020, CAR-T cells hit the tumor microenvironment: strategies to overcome tumor escape, Frontiers in Immunology, 11: 1109. https://doi.org/10.3389/fimmu.2020.01109 Sorkhabi A., Khosroshahi L., Sarkesh A., Mardi A., Aghebati-Maleki A., Aghebati-Maleki L., and Baradaran B., 2023, The current landscape of CAR T-cell therapy for solid tumors: mechanisms research progress challenges and counterstrategies, Frontiers in Immunology, 14: 1113882. https://doi.org/10.3389/fimmu.2023.1113882 Sterner R., and Sterner R., 2021, CAR-T cell therapy: current limitations and potential strategies, Blood Cancer Journal, 11(4): 69. https://doi.org/10.1038/s41408-021-00459-7 Tony L., Stabile A., Schauer M., Hudecek M., and Weber J., 2025, CAR-T Cell therapy for solid tumors, Transfusion Medicine and Hemotherapy, 52: 96-108. https://doi.org/10.1159/000542438 Wagner J., Wickman E., Derenzo C., and Gottschalk S., 2020, CAR T cell therapy for solid tumors: bright future or dark reality?, Molecular Therapy, 28(11): 2320-2339. https://doi.org/10.1016/j.ymthe.2020.09.015 Yan T., Zhu L., and Chen J., 2023, Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment, Experimental Hematology and Oncology, 12(1): 14. https://doi.org/10.1186/s40164-023-00373-7 Zhang X., Zhu L., Zhang H., Chen S., and Xiao Y., 2022, CAR-T cell therapy in hematological malignancies: current opportunities and challenges, Frontiers in Immunology, 13: 927153. https://doi.org/10.3389/fimmu.2022.927153 Zhu D., Kim W., Lee H., Bao X., and Kim P., 2025 Engineering CAR-T therapeutics for enhanced solid tumor targeting, Advanced Materials, 37(23): e2414882. https://doi.org/10.1002/adma.202414882
RkJQdWJsaXNoZXIy MjQ4ODYzNA==